Inflammation can increase the amount and transcriptional activity of sterol regulatory element-binding protein 1c (SREBP1c), promote liver lipogenesis, and aggravate the development of NAFLD [6, 7]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.